Mechanisms, Detection, and Potential Management of Microcirculatory Disturbances in Sepsis

Critical Care Clinics

Volumn 26, Issue 2, 2010, Pages 393-408

  Mohammed, Imran ^a   Nonas, Stephanie A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Microcirculatory disturbances; Microvascular blood flow; Microvascular perfusion; Sepsis

Indexed keywords

ADRENALIN; BOSENTAN; DOBUTAMINE; DROTRECOGIN; ENDOTHELIN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HYPERTENSIVE FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; NORADRENALIN; PENTOXIFYLLINE; PROSTACYCLIN; TEZOSENTAN; VASODILATOR AGENT;

ACUTE HEART INFARCTION; ANTIINFLAMMATORY ACTIVITY; BLOOD CARBON DIOXIDE TENSION; BLOOD FLOW VELOCITY; CAPNOGRAPHY; DRUG POTENCY; FLOW MEASUREMENT; FLUORESCENCE MICROSCOPY; GAS EXCHANGE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; HYPERTENSION; IMAGE ANALYSIS; INOTROPISM; LASER DOPPLER FLOWMETRY; LOW DRUG DOSE; MICROANGIOPATHY; MICROCIRCULATION; MICROSCOPY; NONHUMAN; NUTRIENT UPTAKE; ORTHOGONAL POLARIZATION SPECTRAL IMAGING; OXYGEN TRANSPORT; PERIPHERAL VASCULAR DISEASE; POLAROGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK; SIDESTREAM DARK FIELD IMAGING; TISSUE OXYGENATION;

HUMANS; MICROCIRCULATION; SEPSIS; VASCULAR DISEASES;

EID: 77951183423     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2010.01.003     Document Type: Review

References (83)

1. Matot I., Sprung C.L. Definition of sepsis. Intensive Care Med 2001, 27(Suppl 1):S3-S9.
2. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29(7):1303-1310.
3. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345(19):1368-1377.
4. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
5. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005, 9(Suppl 4):S13-S19.
6. Vincent J.L., De Backer D. Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Crit Care 2005, 9(Suppl 4):S9-12.
7. Sakr Y., Dubois M.J., De Backer D., et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004, 32(9):1825-1831.
8. Trzeciak S., Dellinger R.P., Parrillo J.E., et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007, 49(1):88-98. 98 e1-2.
9. Trzeciak S., Rivers E.P. Clinical manifestations of disordered microcirculatory perfusion in severe sepsis. Crit Care 2005, 9(Suppl 4):S20-S26.
10. Ellis C.G., Jagger J., Sharpe M. The microcirculation as a functional system. Crit Care 2005, 9(Suppl 4):S3-S8.
11. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101(10):3765-3777.
12. Lush C.W., Kvietys P.R. Microvascular dysfunction in sepsis. Microcirculation 2000, 7(2):83-101.
13. Krejci V., Hiltebrand L.B., Sigurdsson G.H. Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Crit Care Med 2006, 34(5):1456-1463.
14. Trzeciak S., McCoy J.V., Dellinger P.R., et al. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008, 34(12):2210-2217.
15. Astiz M.E., DeGent G.E., Lin R.Y., et al. Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med 1995, 23(2):265-271.
16. Astiz M.E., Rackow E.C., Falk J.L., et al. Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med 1987, 15(1):26-28.
17. Schouten M., Wiersinga W.J., Levi M., et al. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008, 83(3):536-545.
18. Diehl J.L., Borgel D. Sepsis and coagulation. Curr Opin Crit Care 2005, 11(5):454-460.
19. Faust S.N., Levin M., Harrison O.B., et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001, 345(6):408-416.
20. Looney M.R., Matthay M.A. Bench-to-bedside review: the role of activated protein C in maintaining endothelial tight junction function and its relationship to organ injury. Crit Care 2006, 10(6):239.
21. Kanji S., Devlin J.W., Piekos K.A., et al. Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis. Pharmacotherapy 2001, 21(11):1389-1402.
22. Martin G., Brunkhorst F.M., Janes J.M., et al. The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes. Crit Care 2009, 13(3):R103.
23. De Backer D., Verdant C., Chierego M., et al. Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med 2006, 34(7):1918-1924.
24. Piagnerelli M., Boudjeltia K.Z., Vanhaeverbeek M., et al. Red blood cell rheology in sepsis. Intensive Care Med 2003, 29(7):1052-1061.
25. Chien S. Rheology in the microcirculation in normal and low flow states. Adv Shock Res 1982, 8:71-80.
26. Hinshaw L.B. Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 1996, 24(6):1072-1078.
27. Secchi M.E., Sulli A., Pizzorni C., et al. Reumatismo 2009, 61(1):34-40. [in Italian].
28. De Backer D. OPS techniques. Minerva Anestesiol 2003, 69(5):388-391.
29. Harris A.G., Sinitsina I., Messmer K. The cytoscan model E-II, a new reflectance microscope for intravital microscopy: comparison with the standard fluorescence method. J Vasc Res 2000, 37(6):469-476.
30. Boerma E.C., Mathura K.R., van der Voort P.H., et al. Quantifying bedside-derived imaging of microcirculatory abnormalities in septic patients: a prospective validation study. Crit Care 2005, 9(6):R601-R606.
31. Hiltebrand L.B., Krejci V., Sigurdsson G.H. Effects of dopamine, dobutamine, and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia. Anesthesiology 2004, 100(5):1188-1197.
32. Creteur J., De Backer D., Sakr Y., et al. Sublingual capnometry tracks microcirculatory changes in septic patients. Intensive Care Med 2006, 32(4):516-523.
33. Fries M., Weil M.H., Sun S., et al. Increases in tissue Pco2 during circulatory shock reflect selective decreases in capillary blood flow. Crit Care Med 2006, 34(2):446-452.
34. Marik P.E. Regional carbon dioxide monitoring to assess the adequacy of tissue perfusion. Curr Opin Crit Care 2005, 11(3):245-251.
35. De Backer D., Hollenberg S., Boerma C., et al. How to evaluate the microcirculation: report of a round table conference. Crit Care 2007, 11(5):R101.
36. Piper R.D., Pitt-Hyde M., Li F., et al. Microcirculatory changes in rat skeletal muscle in sepsis. Am J Respir Crit Care Med 1996, 154(4 Pt 1):931-937.
37. Farquhar I., Martin C.M., Lam C., et al. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res 1996, 61(1):190-196.
38. Hiltebrand L.B., Krejci V., Banic A., et al. Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock. Crit Care Med 2000, 28(9):3233-3241.
39. Hiltebrand L.B., Krejci V., tenHoevel M.E., et al. Redistribution of microcirculatory blood flow within the intestinal wall during sepsis and general anesthesia. Anesthesiology 2003, 98(3):658-669.
40. Krejci V., Hiltebrand L., Banic A., et al. Continuous measurements of microcirculatory blood flow in gastrointestinal organs during acute haemorrhage. Br J Anaesth 2000, 84(4):468-475.
41. Koo A., Tse T.F., Yu D.Y. Hepatic microvascular effects of terbutaline in experimental cardiogenic shock in rats. Clin Exp Pharmacol Physiol 1979, 6(5):495-506.
42. Fries M., Weil M.H., Chang Y.T., et al. Microcirculation during cardiac arrest and resuscitation. Crit Care Med 2006, 34(Suppl 12):S454-S457.
43. Neviere R., Mathieu D., Chagnon J.L., et al. Skeletal muscle microvascular blood flow and oxygen transport in patients with severe sepsis. Am J Respir Crit Care Med 1996, 153(1):191-195.
44. Kubli S., Boegli Y., Ave A.D., et al. Endothelium-dependent vasodilation in the skin microcirculation of patients with septic shock. Shock 2003, 19(3):274-280.
45. Marik P.E. Sublingual capnography: a clinical validation study. Chest 2001, 120(3):923-927.
46. Marik P.E., Bankov A. Sublingual capnometry versus traditional markers of tissue oxygenation in critically ill patients. Crit Care Med 2003, 31(3):818-822.
47. De Backer D., Creteur J., Preiser J.C., et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166(1):98-104.
48. Creteur J., Carollo T., Soldati G., et al. The prognostic value of muscle StO2 in septic patients. Intensive Care Med 2007, 33(9):1549-1556.
49. Krejci V., Hiltebrand L.B., Jakob S.M., et al. Vasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow. Crit Care 2007, 11(6):R129.
50. Hiltebrand L.B., Krejci V., Jakob S.M., et al. Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock. Anesthesiology 2007, 106(6):1156-1167.
51. Duranteau J., Sitbon P., Teboul J.L., et al. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999, 27(5):893-900.
52. De Backer D., Creteur J., Silva E., et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?. Crit Care Med 2003, 31(6):1659-1667.
53. Jhanji S., Stirling S., Patel N., et al. The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med 2009, 37(6):1961-1966.
54. Neviere R., Mathieu D., Chagnon J.L., et al. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996, 154(6 Pt 1):1684-1688.
55. Ruokonen E., Takala J., Kari A., et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993, 21(9):1296-1303.
56. van Haren F.M., Rozendaal F.W., van der Hoeven J.G. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 2003, 124(6):2256-2260.
57. Dunser M.W., Mayr A.J., Ulmer H., et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003, 107(18):2313-2319.
58. Gutierrez G., Clark C., Brown S.D., et al. Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 1994, 150(2):324-329.
59. Lange M., Enkhbaatar P., Nakano Y., et al. Role of nitric oxide in shock: the large animal perspective. Front Biosci 2009, 14:1979-1989.
60. Pullamsetti S.S., Maring D., Ghofrani H.A., et al. Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock. Thromb Haemost 2006, 95(4):720-727.
61. Lopez A., Lorente J.A., Steingrub J., et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004, 32(1):21-30.
62. Assadi A., Desebbe O., Kaminski C., et al. Effects of sodium nitroprusside on splanchnic microcirculation in a resuscitated porcine model of septic shock. Br J Anaesth 2008, 100(1):55-65.
63. Gundersen Y., Corso C.O., Leiderer R., et al. The nitric oxide donor sodium nitroprusside protects against hepatic microcirculatory dysfunction in early endotoxaemia. Intensive Care Med 1998, 24(12):1257-1263.
64. Spronk P.E., Ince C., Gardien M.J., et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002, 360(9343):1395-1396.
65. Boerma E.C., Koopmans M., Konijn A., et al. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial. Crit Care Med 2009, 38:93-100.
66. Radermacher P., Buhl R., Santak B., et al. The effects of prostacyclin on gastric intramucosal pH in patients with septic shock. Intensive Care Med 1995, 21(5):414-421.
67. Eichelbronner O., Reinelt H., Wiedeck H., et al. Aerosolized prostacyclin and inhaled nitric oxide in septic shock-different effects on splanchnic oxygenation?. Intensive Care Med 1996, 22(9):880-887.
68. Kimura D., Totapally B.R., Raszynski A., et al. The effects of CO2 on cytokine concentrations in endotoxin-stimulated human whole blood. Crit Care Med 2008, 36(10):2823-2827.
69. Hanly E.J., Fuentes J.M., Aurora A.R., et al. Carbon dioxide pneumoperitoneum prevents mortality from sepsis. Surg Endosc 2006, 20(9):1482-1487.
70. Hanly E.J., Bachman S.L., Marohn M.R., et al. Carbon dioxide pneumoperitoneum-mediated attenuation of the inflammatory response is independent of systemic acidosis. Surgery 2005, 137(5):559-566.
71. Gnaegi A., Feihl F., Boulat O., et al. Moderate hypercapnia exerts beneficial effects on splanchnic energy metabolism during endotoxemia. Intensive Care Med 2009, 35(7):1297-1304.
72. Taccone F.S., Castanares-Zapatero D., Peres-Bota D., et al. Cerebral autoregulation is influenced by carbon dioxide levels in patients with septic shock. Neurocrit Care 2010, 12(1):35-42.
73. Conrad S.A., Dietrich K.A., Hebert C.A., et al. Effect of red cell transfusion on oxygen consumption following fluid resuscitation in septic shock. Circ Shock 1990, 31(4):419-429.
74. Sakr Y., Chierego M., Piagnerelli M., et al. Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med 2007, 35(7):1639-1644.
75. Buchele G.L., Silva E., Ospina-Tascon G.A., et al. Effects of hydrocortisone on microcirculatory alterations in patients with septic shock. Crit Care Med 2009, 37(4):1341-1347.
76. Krysztopik R.J., Bentley F.R., Wilson M.A., et al. Vasomotor response to pentoxifylline mediates improved renal blood flow to bacteremia. J Surg Res 1996, 63(1):17-22.
77. Krysztopik R.J., Matheson P.J., Spain D.A., et al. Lazaroid and pentoxifylline suppress sepsis-induced increases in renal vascular resistance via altered arachidonic acid metabolism. J Surg Res 2000, 93(1):75-81.
78. Piechota M., Banach M., Irzmanski R., et al. Plasma endothelin-1 levels in septic patients. J Intensive Care Med 2007, 22(4):232-239.
79. Sanai L., Haynes W.G., MacKenzie A., et al. Endothelin production in sepsis and the adult respiratory distress syndrome. Intensive Care Med 1996, 22(1):52-56.
80. Schuetz P., Christ-Crain M., Morgenthaler N.G., et al. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium 2007, 14(6):345-351.
81. Krejci V., Hiltebrand L.B., Erni D., et al. Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock. Crit Care Med 2003, 31(1):203-210.
82. Andersson A., Fenhammar J., Frithiof R., et al. Mixed endothelin receptor antagonism with tezosentan improves intestinal microcirculation in endotoxemic shock. J Surg Res 2008, 149(1):138-147.
83. Fenhammar J., Andersson A., Frithiof R., et al. The endothelin receptor antagonist tezosentan improves renal microcirculation in a porcine model of endotoxemic shock. Acta Anaesthesiol Scand 2008, 52(10):1385-1393.